Indications for Procedures in Gastric Outlet Obstruction Due to Peptic Ulcer
Endoscopic Balloon Dilation
Endoscopic balloon dilation is the first-line intervention for benign gastric outlet obstruction from peptic ulcer disease when obstruction persists after 7-10 days of intravenous double-dose PPI therapy. 1
Specific indications:
- Pyloro-bulbar stenosis confirmed endoscopically
- Failed medical management (IV PPI for 7-10 days)
- Patient stable enough to tolerate endoscopy
- No evidence of perforation or active bleeding requiring surgery
Clinical context: This achieves immediate success in 95.5% of cases with long-term remission (>30 months) in 55.8% of patients 1. The procedure is simple, effective, and safe with only 6.7% complication rate (perforation, bleeding) 1. Approximately 65% achieve sustained symptom relief, though multiple sessions may be needed 2.
Critical caveat: Success depends on concurrent H. pylori eradication (present in 97.7% of cases) and smoking cessation—failure of H. pylori eradication is associated with stenosis relapse 1.
Endoscopic Self-Expanding Metal Stent (SEMS) Placement
SEMS placement is indicated primarily for malignant gastric outlet obstruction, NOT as first-line therapy for benign peptic ulcer disease. 3, 4
Specific indications for peptic ulcer disease:
- Palliation in patients with severe comorbidities who cannot tolerate surgery
- Delayed diagnosis with significant fibrosis
- Bridge to surgery when surgical closure would be technically difficult
- Combined with laparoscopic drain placement in selected cases 5
Important limitation: SEMS is not recognized as a standard approach for perforated peptic ulcer and needs further validation 5. For benign disease, balloon dilation remains superior due to lower reintervention rates.
Surgical Gastrojejunostomy
Surgical gastrojejunostomy is indicated when endoscopic balloon dilation fails or when there are contraindications to endoscopic therapy. 2, 6
Specific indications:
- Failed endoscopic balloon dilation (after multiple attempts)
- Recurrent stenosis despite optimal medical therapy and H. pylori eradication
- Large perforations (≥2 cm) requiring damage control 5
- Patient preference after informed discussion of risks
Clinical outcomes: Surgery carries significant morbidity and mortality, particularly in elderly patients (>70 years) 7. Recent evidence shows surgical gastrojejunostomy has higher rates of adverse events (38.9% vs 7.9% for endoscopic approaches), longer hospitalization (median 9 vs 3 days), and slower return to solid diet (5 vs 2 days) 6.
Modern consideration: EUS-guided gastroenterostomy is emerging as superior to traditional surgery with better outcomes, but this applies more to malignant obstruction 6, 8.
Pyloroplasty
Pyloroplasty (Heineke-Mikulicz or Finney techniques) is indicated for benign gastric outlet obstruction when non-operative treatment fails and the pylorus requires operative intervention. 9
Specific indications:
- Failed endoscopic balloon dilation requiring surgery
- Small perforations (<2 cm) that can be incorporated into the pyloroplasty 5
- Intraoperative finding of pyloric stenosis during surgery for other peptic ulcer complications
- Preference for pylorus-preserving procedure when feasible
Technical note: This procedure is less commonly performed in the modern era due to effective medical management, so surgeon experience may be limited 9. It's appropriate when the obstruction is localized to the pylorus without extensive duodenal involvement.
Antrectomy with Vagotomy
Antrectomy with vagotomy is indicated for refractory peptic ulcer disease with gastric outlet obstruction when definitive surgical treatment is required. 7
Specific indications:
- Failed endoscopic and medical management
- Recurrent obstruction despite multiple interventions
- Concurrent complications (bleeding, perforation) requiring resection
- Gastric ulcer with obstruction where malignancy cannot be excluded
Clinical context: This represents definitive treatment addressing both the obstruction and the underlying acid hypersecretion. However, it carries higher morbidity than simpler procedures and is reserved for cases requiring gastric resection.
Billroth II Gastrojejunostomy (Gastric Resection with Gastrojejunal Anastomosis)
Billroth II reconstruction is indicated as the method of choice for gastric outlet obstruction requiring gastric resection, particularly when duodenal involvement precludes Billroth I reconstruction. 7
Specific indications:
- Extensive duodenal scarring preventing Billroth I (gastroduodenal) anastomosis
- Large gastric ulcers with obstruction requiring resection
- Failed pyloroplasty or previous surgical interventions
- Concurrent gastric pathology requiring resection
Preferred alternative: When technically feasible, Billroth I reconstruction (gastroduodenal anastomosis) is preferred as it preserves normal duodenal passage and decreases postresection syndromes (97.5% excellent results vs lower rates with Billroth II) 7. The Haberer-Andreoiu modification improves outcomes 7.
Critical consideration: Main mortality factors are age >70 years (average age of deaths: 76.3 years) and serious concurrent medical illness 7.
Clinical Algorithm Summary
- Initial management: IV double-dose PPI × 7-10 days + H. pylori eradication
- Persistent obstruction: Endoscopic balloon dilation (first-line)
- Failed dilation or recurrence: Repeat dilation (up to 2-3 attempts) with optimized medical therapy
- Multiple failures: Surgical intervention (pyloroplasty if localized, gastrojejunostomy/resection if extensive)
- Poor surgical candidate: Consider SEMS as palliation (off-label for benign disease)
Surgery should be performed as soon as possible when indicated, as every hour of delay decreases survival probability by 2.4% 5.